L. Puga

Endothelial markers and HIV infection in the era of highly active antiretroviral treatment

Gabriela de Larrañaga, Andrea Bocassi, L. Puga et al. · Thrombosis Research · 2003 · 56 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV–HCV–coinfected patients under highly active antiretroviral treatment

Gabriela de Larrañaga, Silvia Perés Wingeyer, L. Puga et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2006 · 38 citations

Life Sciences, Immunology, Infectious Diseases +15

TRH injected into the nucleus accumbens shell releases dopamine and reduces feeding motivation in rats

L. Puga, Viridiana Alcántara‐Alonso, Ulises Coffeen et al. · Behavioural Brain Research · 2016 · 23 citations

Life Sciences, Neurobiology, Neuroscience +14

Thrombophilia in Human Immunodeficiency Virus—Infected Patients with Osteonecrosis: Is There a Real Connection? The First Case-Control Study

Gabriela de Larrañaga, Edgardo Bottaro, Marta Martinuzzo et al. · Clinical and Applied Thrombosis/Hemostasis · 2007 · 14 citations

Medicine, Immunology, Orthopaedic Surgery +10